3 Point Analysis | Ranitidine Ban Impact

Recent news flows regarding a potential ban on drug used for acid reflux - Raniti-dine had a knee-jerk impact on some of the Indian pharma and API companies.

Sakshi Batra does a 3 point analysis of why this drug is under the lens and what could this mean for pharma and API companies